FDA’s M. Khair ElZarrad to Keynote Session II of Johns Hopkins APL’s National Health Virtual Speaker Series
M. Khair ElZarrad, the Deputy Director of the Office of Medical Policy in the Center for Drug Evaluation and Research at the Food and Drug Administration, will be the featured speaker in the July…
Read the full articleYou might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Medicinal plants used to treat infectious diseases in French Polynesia: an ethnobotanical survey and antibacterial evaluation
archimer.ifremer.fr·just now
Unveiling the subchronic effects of PFAS mixtures in blue mussels (Mytilus spp.): An integrative assessment from molecular to physiological levels
archimer.ifremer.fr·just now
A standardized method to monitor marine litter in submarine canyons: implementation in Atlantic and Mediterranean reef ecosystems
archimer.ifremer.fr·just now
Microplastics in the marine environment: development of a new citizen science tool
archimer.ifremer.fr·just now
Global sensitivity analysis of a complex marine ecosystem model: Advancing the understanding of ecosystem functioning
archimer.ifremer.fr·just now
Comments
Sign in to join the conversation.
No comments yet. Be the first.